Quantum Computing Inc. approaches its fourth quarter fiscal 2025 earnings announcement scheduled for Monday, March 2, 2026, with recent price weakness creating uncertainty among shareholders. The stock experienced an 8.4% decline on February 27, closing at $8.278.
Quantum Computing, Inc., QUBT
Daily trading activity registered approximately 3.37 million shares — representing a dramatic 78% reduction compared to the typical 15 million share average. This significantly lighter volume during the selloff may indicate limited selling pressure, though the implications remain subject to interpretation.
Technically, shares are positioned beneath both the 50-day moving average at $10.35 and the 200-day moving average at $13.70. Despite recent weakness, QUBT maintains gains exceeding 39% over the trailing twelve months, propelled primarily by enthusiasm surrounding its photonic computing platform.
The Street’s consensus estimate calls for a quarterly loss of $0.02 per share in Q4 2025. This figure represents substantial improvement compared to the $0.47 per share deficit recorded in the year-ago period.
On the top line, analysts anticipate revenues reaching $390K, a meaningful increase from the $62K generated in Q4 2024. Though absolute dollar amounts remain modest, the growth trajectory is capturing attention from market observers.
A significant narrative entering the earnings discussion involves the company’s $110 million all-cash purchase of Luminar Semiconductor Inc., formerly held by Luminar Technologies. This strategic transaction aims to provide QUBT with greater vertical integration and enhanced capability to generate consistent revenue streams.
Market participants will be focused on management commentary regarding semiconductor manufacturing schedules, fulfillment of existing orders, and any preliminary indicators of revenue acceleration stemming from the acquisition.
The analyst community presents a varied outlook. Lake Street analyst Max Michaelis maintained his Buy recommendation while adjusting his price objective from $24 down to $16 — nonetheless suggesting approximately 77% appreciation potential from current trading levels.
Ascendiant Capital Markets similarly reduced its target from $40 to $25 while preserving a Buy stance. Taking a more reserved approach, Wedbush established coverage with a Neutral rating and $12 price target, while Cantor Fitzgerald reaffirmed its Neutral position with a $15 target.
Rosenblatt Securities launched coverage in January with a Buy rating and $22 price objective. The aggregate consensus stands at Moderate Buy, comprising one Strong Buy, two Buys, two Holds, and one Sell among analysts providing coverage.
The mean price target across all tracked analysts reaches $18.00, implying approximately 99% upside from the February 27 trading price.
QUBT exhibits a beta coefficient of 3.44, indicating heightened volatility relative to broader market movements. The company maintains a market capitalization near $1.83 billion, with a negative P/E ratio of -13.40 consistent with its current unprofitable state.
Company insiders control 19.3% of outstanding shares. COO Milan Begliarbekov divested 2,860 shares on January 7 at $11.85 per share, trimming his holdings by approximately 10.55%. Institutional ownership remains minimal at 4.26%.
Options market activity suggests traders are anticipating a potential price movement of roughly 14.05% in either direction once earnings results are released.
The company will publish Q4 FY25 financial results prior to the market opening on March 2, 2026.
The post QUBT Earnings Preview: What Investors Should Know Before March 2 appeared first on Blockonomi.


